Trial Profile
A open label cohort, international, multicentre and investigator initiated study to evaluate the add-on therapy with entecavir plus tenofovir due to viral resistance or partial responses followed by monotherapy in chronic hepatitis B patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Tenofovir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 19 Dec 2015 New trial record